Who We are and what we do

OUR History

Our Mission

To establish ourselves as a leader in the generic pharmaceutical market by providing superior quality products and outstanding services to the healthcare community. We are committed to being a trusted business partner to all stakeholders patients, customers, investors, distributors, suppliers and employees by fostering integrity, synergy and mutual trust to achieve shared success.

Our Vision

PHARAONIA PHARMACEUTICALS aspires to be one of the top pharmaceutical leaders in Egypt, targeting a place among the top ten generic manufacturers in the region, driven by our unwavering commitment to quality and our passion for enhancing health and wellness.

Our Core Values

Board of directors

Chairman

Mr. Meshal Abdullah Aljassar

Vice Chairman

Dr. Abdullah Monged Badr

BOD Member

Dr. Mohamed Faisal Alqenai

BOD Member

Mr. Ali Attalah Al-Mutairi

BOD Member

Dr. Nasser Metwaly Alnomrosy

د صلاح عبدالصادق موسي

Group Chief Executive Officer

Dr. Salah Adelsadek Mousa

executive leadership team

Our experienced leadership team keeps us on track

Group Chief Technical Affairs Officer

Dr. Ahmed Ezz El Din

Group Marketing & Business Development Senior Director

Dr. Khalid Ibrahim

Group Chief Commercial Officer

Dr. Ahmed Azouz

Group Regulatory Affairs Officer

Dr. Iman Fada

Medical & Pharmacovigilance Director

Dr. Alaa Eldin Abo Elyazid

Supply Chain Manager

Eng. Rehab Refaat

Legal Affairs Director

Mr. Youssef El-Moslemany

Finance Director

Mr. Ayman Salah

Group Information Technology Director

Mr. Mohamed Mostafa

Group Internal Audit Director

Mr. Islam Samir

Group Compliance and Risk Management Director

Mr. Mohamed Haassan

Group Head of Human Resources and Administration

Mr. Mohamed Nasr

Certification and Authorizations

ISO 9001 :2015

For the following activities Manufacturing of pharmaceuticals for human and veterinary (Local market, Tender and Export)
This certificate is valid from 22 December 2021 until 15 December 2024 and remains valid subject to satisfactory surveillance audits. Recertification audit due a minimum of 60 days before the expiration date. Issue 4. Certified since 15 December 2015

ISO 14001 :2015

For the following activities Manufacturing of pharmaceuticals for human and veterinary (Local market, Tender and Export)
This certificate is valid from 22 December 2021 until 15 December 2024 and remains valid subject to satisfactory surveillance audits. Recertification audit due a minimum of 60 days before the expiration date. issue 4. Certified since 15 December 2015

ISO 45001 :2018

For the following activities Manufacturing of pharmaceuticals for human and veterinary (Local market, Tender and Export)
This certificate is valid from 22 December 2021 until 13 December 2024 and remains valid subject to satisfactory surveillance audits. Recef!ification audit due a minimum of 60 days before the expiration date. Issue 3. Certified since 26 February 2021